Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Holding KYMR?
Track your performance easily

Kymera Therapeutics (KYMR) Ownership - Who Owns Kymera Therapeutics?

203 Followers

Kymera Therapeutics (KYMR) Ownership Overview

28.25%28.57%0.15%13.11%29.93%
28.25% Insiders
0.15% Other Institutional Investors
13.11% ETFs
29.93% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 41.83% of the company’s stock is owned by Institutional Investors, 28.25% is owned by Insiders, and 29.93% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 22, 2024
xxxxxxxxxxxxx
$46
May 23, 2024
xxxxxxxxxxxxx
$90099
Mar 04, 2024
xxxxxxxxxxxxx
$139956
Mar 04, 2024
xxxxxxxxxxxxx
$164651

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$3902260
Jun 30, 2024
xxxxxxxxxxxxx
$6668878
Jun 30, 2024
xxxxxxxxxxxxx
$15456240

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,995,929Insider9.26%285,945,854
5,995,928Institution9.26%285,945,806
5,504,905Insider8.50%262,528,919
5,054,898Insider7.80%241,068,086
4,493,888Institution6.94%214,313,519
4,129,291Institution6.38%196,925,888
2,979,548Institution4.60%142,094,644
2,606,981Institution4.03%124,326,924
2,157,780Institution3.33%102,904,528
1,446,764Institution2.23%68,996,175

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,129,291Institution6.38%196,925,888
2,979,548Institution4.60%142,094,644
2,606,981Institution4.03%124,326,924
1,446,764Institution2.23%68,996,175
1,228,800Institution1.90%58,601,472
873,677Institution1.35%41,665,656
619,308Institution0.96%29,534,799
495,303Institution0.76%23,621,000
480,178Institution0.74%22,899,689
462,099Institution0.71%22,037,501

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,544,048Institution2.38%73,079,792
1,207,833Institution1.86%57,166,736
1,146,232Institution1.77%53,953,140
703,646Institution1.09%32,698,430
671,595Institution1.04%31,786,591
666,760Institution1.03%31,557,751
402,076Institution0.62%18,925,717
395,289Institution0.61%18,606,253
215,446Institution0.33%10,011,776
203,914Institution0.31%9,651,250

FAQ

Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 28.25% is held by insiders, and 29.93% is held by retail investors.
    What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.15% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
      What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 29.93% of Kymera Therapeutics (KYMR) stock is held by retail investors.
        Who owns the most shares of Kymera Therapeutics (KYMR)?
        Baker Bros. Advisors Lp owns the most shares of Kymera Therapeutics (KYMR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis